These 5 Stocks Saw Trading Price Swings This Past Week Post Earnings

Cross Country Healthcare, Inc. (NASDAQ:CCRN) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased to $-0.01 in the quarter versus EPS of $0.00 in the year-earlier quarter. Revenue Decreased 12.92% to $110.3 million from the year-earlier quarter.

Cross Country Healthcare, Inc. reported adjusted EPS loss of $0.01 per share. By that measure, the company missed the mean analyst estimate of $0. It missed the average revenue estimate of $111.77 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

CCRN

McKesson Corporation (NYSE:MCK) delivered a profit and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased 30.62% to $1.45 in the quarter versus EPS of $2.09 in the year-earlier quarter. Revenue Decreased 3.4% to $30.62 billion from the year-earlier quarter.

McKesson Corporation reported adjusted EPS income of $1.45 per share. By that measure, the company missed the mean analyst estimate of $2.30. It missed the average revenue estimate of $32.01 billion.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

MCK

Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased 50.55% to $1.37 in the quarter versus EPS of $0.91 in the year-earlier quarter. Revenue Rose 80.98% to $196.2 million from the year-earlier quarter.

Jazz Pharmaceuticals, Inc. reported adjusted EPS income of $1.37 per share. By that measure, the company beat the mean analyst estimate of $1.35. It beat the average revenue estimate of $189.92 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

JAZZ

Onyx Pharmaceuticals Inc. (NASDAQ:ONXX) had a loss and met Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased to $-0.47 in the quarter versus EPS of $-0.68 in the year-earlier quarter. Revenue Rose 102% to $145.5 million from the year-earlier quarter.

Onyx Pharmaceuticals Inc. reported adjusted EPS loss of $0.47 per share. By that measure, the company met the mean analyst estimate of $-0.47. It beat the average revenue estimate of $134.36 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

ONXX

Myriad Genetics Inc. (NASDAQ:MYGN) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased 35.29% to $0.46 in the quarter versus EPS of $0.34 in the year-earlier quarter. Revenue Rose 20.51% to $156.4 million from the year-earlier quarter.

Myriad Genetics Inc. reported adjusted EPS income of $0.46 per share. By that measure, the company beat the mean analyst estimate of $0.40. It beat the average revenue estimate of $148.25 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

MYGN

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.

More from The Cheat Sheet